Company intelligence / Profile preview
ProAbTech
Gwangju, Gwangju, South Koreaproabtech.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
ProAbTech’s lead program PAT101 is in Phase 1 clinical trials for chronic tophaceous gout. Other programs are at the preclinical or discovery stage targeting liver cancer, obesity, sepsis, and lung cancer. The company leverages proprietary bioconjugation technology to develop next-generation biological drugs with improved pharmacokinetics and reduced immunogenicity[3][4].
- Therapeutic areas
- OncologyEndocrinologyRheumatologyInfectious Diseases
- Modalities
- Protein drugsRecombinant polypeptidesAntibody-drug conjugates (bioconjugates)
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Albumedix Ltd. (supply agreement for recombinant human serum albumin)[2]Quratis (production contract for PAT101)[2]Charles River Laboratories (contract for non-clinical studies of PAT101)[2]
Beyond the preview
Go deeper on ProAbTech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ProAbTech.